BeOne Medicines
ONC
#652
Rank
HK$278.14 B
Marketcap
HK$2,514
Share price
-2.56%
Change (1 day)
57.13%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

BeOne Medicines (ONC) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : HK$27.27 Billion

According to BeOne Medicines's latest financial reports the company's total liabilities are HK$27.27 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BeOne Medicines - Total liabilities on balance sheet (from 2014 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31HK$20.09 B13.46%
2023-12-31HK$17.71 B13.58%
2022-12-31HK$15.59 B-16.77%
2021-12-31HK$18.73 B39.59%
2020-12-31HK$13.42 B171.88%
2019-12-31HK$4.93 B27.1%
2018-12-31HK$3.88 B37.25%
2017-12-31HK$2.83 B589.86%
2016-12-31HK$0.41 B24.71%
2015-12-31HK$0.32 B52.28%
2014-12-31HK$0.21 B-44.86%
2013-12-31HK$0.39 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Onconova Therapeutics
ONTX
HK$94.63 M-99.65%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
HK$5.37 B-80.30%๐Ÿ‡บ๐Ÿ‡ธ USA